vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and DNOW Inc. (DNOW). Click either name above to swap in a different company.

APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $959.0M, roughly 1.0× DNOW Inc.). APTARGROUP, INC. runs the higher net margin — 7.7% vs -16.8%, a 24.5% gap on every dollar of revenue. On growth, DNOW Inc. posted the faster year-over-year revenue change (68.0% vs 13.5%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $76.0M). Over the past eight quarters, DNOW Inc.'s revenue compounded faster (30.5% CAGR vs 2.6%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

DNOW Inc., operating under the trade name DistributionNOW, is a global industrial and energy products distributor. It provides supply chain management, inventory optimization, and technical support services, offering parts, equipment, and consumables for oil and gas, renewable energy, manufacturing, and construction sectors, with operations spanning North America, Europe, and Asia-Pacific.

ATR vs DNOW — Head-to-Head

Bigger by revenue
ATR
ATR
1.0× larger
ATR
$962.7M
$959.0M
DNOW
Growing faster (revenue YoY)
DNOW
DNOW
+54.4% gap
DNOW
68.0%
13.5%
ATR
Higher net margin
ATR
ATR
24.5% more per $
ATR
7.7%
-16.8%
DNOW
More free cash flow
ATR
ATR
$20.9M more FCF
ATR
$96.9M
$76.0M
DNOW
Faster 2-yr revenue CAGR
DNOW
DNOW
Annualised
DNOW
30.5%
2.6%
ATR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATR
ATR
DNOW
DNOW
Revenue
$962.7M
$959.0M
Net Profit
$74.3M
$-161.0M
Gross Margin
5.2%
Operating Margin
11.0%
-19.6%
Net Margin
7.7%
-16.8%
Revenue YoY
13.5%
68.0%
Net Profit YoY
-26.4%
-905.0%
EPS (diluted)
$1.13
$-1.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
DNOW
DNOW
Q4 25
$962.7M
$959.0M
Q3 25
$961.1M
$634.0M
Q2 25
$966.0M
$628.0M
Q1 25
$887.3M
$599.0M
Q4 24
$848.1M
$571.0M
Q3 24
$909.3M
$606.0M
Q2 24
$910.1M
$633.0M
Q1 24
$915.4M
$563.0M
Net Profit
ATR
ATR
DNOW
DNOW
Q4 25
$74.3M
$-161.0M
Q3 25
$127.9M
$25.0M
Q2 25
$111.7M
$25.0M
Q1 25
$78.8M
$22.0M
Q4 24
$100.9M
$20.0M
Q3 24
$100.0M
$13.0M
Q2 24
$90.5M
$24.0M
Q1 24
$83.1M
$21.0M
Gross Margin
ATR
ATR
DNOW
DNOW
Q4 25
5.2%
Q3 25
22.9%
Q2 25
22.9%
Q1 25
23.2%
Q4 24
22.6%
Q3 24
22.3%
Q2 24
21.8%
Q1 24
22.9%
Operating Margin
ATR
ATR
DNOW
DNOW
Q4 25
11.0%
-19.6%
Q3 25
14.2%
5.2%
Q2 25
14.9%
5.1%
Q1 25
12.8%
5.0%
Q4 24
14.2%
4.4%
Q3 24
15.2%
3.8%
Q2 24
13.8%
5.2%
Q1 24
12.2%
5.0%
Net Margin
ATR
ATR
DNOW
DNOW
Q4 25
7.7%
-16.8%
Q3 25
13.3%
3.9%
Q2 25
11.6%
4.0%
Q1 25
8.9%
3.7%
Q4 24
11.9%
3.5%
Q3 24
11.0%
2.1%
Q2 24
9.9%
3.8%
Q1 24
9.1%
3.7%
EPS (diluted)
ATR
ATR
DNOW
DNOW
Q4 25
$1.13
$-1.42
Q3 25
$1.92
$0.23
Q2 25
$1.67
$0.23
Q1 25
$1.17
$0.20
Q4 24
$1.48
$0.19
Q3 24
$1.48
$0.12
Q2 24
$1.34
$0.21
Q1 24
$1.23
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
DNOW
DNOW
Cash + ST InvestmentsLiquidity on hand
$409.5M
$164.0M
Total DebtLower is stronger
$1.1B
$411.0M
Stockholders' EquityBook value
$2.7B
$2.2B
Total Assets
$5.3B
$3.9B
Debt / EquityLower = less leverage
0.43×
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
DNOW
DNOW
Q4 25
$409.5M
$164.0M
Q3 25
$264.8M
$266.0M
Q2 25
$169.8M
$232.0M
Q1 25
$136.8M
$219.0M
Q4 24
$226.2M
$256.0M
Q3 24
$327.9M
$261.0M
Q2 24
$223.9M
$197.0M
Q1 24
$201.1M
$188.0M
Total Debt
ATR
ATR
DNOW
DNOW
Q4 25
$1.1B
$411.0M
Q3 25
$546.0M
Q2 25
$535.1M
Q1 25
$561.2M
Q4 24
$688.1M
$0
Q3 24
$822.7M
Q2 24
$681.5M
Q1 24
$680.4M
Stockholders' Equity
ATR
ATR
DNOW
DNOW
Q4 25
$2.7B
$2.2B
Q3 25
$2.8B
$1.2B
Q2 25
$2.7B
$1.2B
Q1 25
$2.5B
$1.1B
Q4 24
$2.5B
$1.1B
Q3 24
$2.5B
$1.1B
Q2 24
$2.4B
$1.1B
Q1 24
$2.3B
$1.1B
Total Assets
ATR
ATR
DNOW
DNOW
Q4 25
$5.3B
$3.9B
Q3 25
$5.1B
$1.7B
Q2 25
$4.9B
$1.7B
Q1 25
$4.5B
$1.7B
Q4 24
$4.4B
$1.6B
Q3 24
$4.6B
$1.6B
Q2 24
$4.5B
$1.6B
Q1 24
$4.4B
$1.6B
Debt / Equity
ATR
ATR
DNOW
DNOW
Q4 25
0.43×
0.18×
Q3 25
0.20×
Q2 25
0.20×
Q1 25
0.22×
Q4 24
0.28×
0.00×
Q3 24
0.32×
Q2 24
0.28×
Q1 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
DNOW
DNOW
Operating Cash FlowLast quarter
$183.7M
$83.0M
Free Cash FlowOCF − Capex
$96.9M
$76.0M
FCF MarginFCF / Revenue
10.1%
7.9%
Capex IntensityCapex / Revenue
9.0%
0.7%
Cash ConversionOCF / Net Profit
2.47×
TTM Free Cash FlowTrailing 4 quarters
$299.6M
$134.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
DNOW
DNOW
Q4 25
$183.7M
$83.0M
Q3 25
$177.6M
$43.0M
Q2 25
$126.0M
$45.0M
Q1 25
$82.7M
$-16.0M
Q4 24
$178.2M
$122.0M
Q3 24
$229.3M
$74.0M
Q2 24
$143.6M
$21.0M
Q1 24
$92.3M
$81.0M
Free Cash Flow
ATR
ATR
DNOW
DNOW
Q4 25
$96.9M
$76.0M
Q3 25
$114.3M
$39.0M
Q2 25
$62.5M
$41.0M
Q1 25
$25.9M
$-22.0M
Q4 24
$112.2M
$119.0M
Q3 24
$162.7M
$72.0M
Q2 24
$75.4M
$18.0M
Q1 24
$16.7M
$80.0M
FCF Margin
ATR
ATR
DNOW
DNOW
Q4 25
10.1%
7.9%
Q3 25
11.9%
6.2%
Q2 25
6.5%
6.5%
Q1 25
2.9%
-3.7%
Q4 24
13.2%
20.8%
Q3 24
17.9%
11.9%
Q2 24
8.3%
2.8%
Q1 24
1.8%
14.2%
Capex Intensity
ATR
ATR
DNOW
DNOW
Q4 25
9.0%
0.7%
Q3 25
6.6%
0.6%
Q2 25
6.6%
0.6%
Q1 25
6.4%
1.0%
Q4 24
7.8%
0.5%
Q3 24
7.3%
0.3%
Q2 24
7.5%
0.5%
Q1 24
8.3%
0.2%
Cash Conversion
ATR
ATR
DNOW
DNOW
Q4 25
2.47×
Q3 25
1.39×
1.72×
Q2 25
1.13×
1.80×
Q1 25
1.05×
-0.73×
Q4 24
1.77×
6.10×
Q3 24
2.29×
5.69×
Q2 24
1.59×
0.88×
Q1 24
1.11×
3.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Pharma Segment$833.1M87%
Other$129.6M13%

DNOW
DNOW

Pipelines$455.0M47%
Downstream And Industrial$196.0M20%
Gas Utilities$183.0M19%
Oil And Gas Properties$105.0M11%
Other$20.0M2%

Related Comparisons